ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.38
0.12%
US Tech 100
21,154.80
-0.50%
S&P 500
6,086.37
0.61%
US Dollar vs CAD
1.43899
-0.03%
Bitcoin
101,621.95
-1.94%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Abivax SA (ABVX) Share Price

Abivax SA

Abivax SA (ABVX)

Abivax
6.23
-0.14
(-2.20%)
Closed January 22 3:00PM
Delayed by 15 minutes
6.23
0.00
( 0.00% )
Pre Market: 3:36AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.23
Bid
6.26
Ask
6.35
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
391.976M
Previous Close
6.23
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
62,917,479
Dividend Yield
-
PE Ratio
-2.61
Earnings Per Share (EPS)
-2.35
Revenue
4.62M
Net Profit
-147.74M

About Abivax SA

Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abivax.com
Headquarters
Paris, Paris, Fra
Founded
-
Abivax SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ABVX. The last closing price for Abivax was US$6.23. Over the last year, Abivax shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Abivax currently has 62,917,479 shares outstanding. The market capitalization of Abivax is US$391.98 million. Abivax has a price to earnings ratio (PE ratio) of -2.61.

Ask ADVFN Intelligence (AI)

ABVX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

January 10 2025
Edgar (US Regulatory)

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224...

January 09 2025
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 23 2024
Edgar (US Regulatory)

Abivax Announces a Change to the Composition of its Board of Directors

Abivax Announces a Change to the Composition of its Board of Directors PARIS, France, December 23, 2024, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the...

December 23 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

November 26 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 19 2024
Edgar (US Regulatory)

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

November 19 2024
GlobeNewswire Inc.

Form F-3 - Registration statement by foreign private issuers

November 19 2024
Edgar (US Regulatory)

Abivax presents third quarter 2024 key financial information

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

November 14 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ABVX - Frequently Asked Questions (FAQ)

What is the current Abivax share price?
The current share price of Abivax is US$ 6.23
How many Abivax shares are in issue?
Abivax has 62,917,479 shares in issue
What is the market cap of Abivax?
The market capitalisation of Abivax is USD 391.98M
What is the 1 year trading range for Abivax share price?
Abivax has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Abivax?
The price to earnings ratio of Abivax is -2.61
What is the cash to sales ratio of Abivax?
The cash to sales ratio of Abivax is 83.38
What is the reporting currency for Abivax?
Abivax reports financial results in EUR
What is the latest annual turnover for Abivax?
The latest annual turnover of Abivax is EUR 4.62M
What is the latest annual profit for Abivax?
The latest annual profit of Abivax is EUR -147.74M
What is the registered address of Abivax?
The registered address for Abivax is 7-11 BOULEVARD HAUSSMANN, PARIS, PARIS, 75009
What is the Abivax website address?
The website address for Abivax is www.abivax.com
Which industry sector does Abivax operate in?
Abivax operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DGNXDiginex Ltd
 18.21
(142.80%)
319.32k
FSEAFirst Seacoast Bancorp Inc
US$ 15.90
(59.00%)
6
BBGIBeasley Broadcast Group Inc
US$ 13.31
(58.45%)
14
FBNCFirst Bancorp
US$ 67.00
(52.62%)
205
CFSBCFSB Bancorp Inc
US$ 11.25
(50.00%)
40
CVBFCVB Financial Corporation
US$ 11.00
(-46.83%)
203
CPBICentral Plains Bancshares Inc
US$ 10.01
(-31.67%)
7
DCOMDime Community Bancshares Inc
US$ 22.00
(-30.71%)
200
TSBKTimberland Bancorp Inc
US$ 21.01
(-27.63%)
12
XNCRXencor Inc
US$ 15.01
(-27.38%)
1
KOPNKopin Corporation
US$ 2.14
(45.58%)
7.43M
HEPAHepion Pharmaceuticals Inc
US$ 0.1599
(18.44%)
4.39M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3289
(3.10%)
3.93M
ASSTAsset Entities Inc
US$ 1.64
(20.59%)
3.4M
SHViShares Short Treasury Bond ETF
US$ 110.38
(0.02%)
3.37M

ABVX Discussion

View Posts
Monksdream Monksdream 4 months ago
ABVX under $15

👍️0

Your Recent History

NASDAQ
ABVX
Abivax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads